glp-1 discovery Frontiers Evolution of GLP‐1 Receptor Agonists

End of Phrase 3: Resolve to C/G (2nd inversion)

The glucagon receptor (GcgR) is the cognate 7-transmembrane G-protein coupled receptor (GPCR) which facilitates transmission of glucagon binding into an intracellular signal

Clinical trials have demonstrated varying degrees of weight loss depending on the specific agent and dosage: semaglutide 2.4mg (Wegovy) produces approximately 15% weight loss at 68 weeks, liraglutide 3mg (Saxenda) typically achieves 5-8% weight loss, while tirzepatide has shown up to 20% weight reduction in obesity trials

No flavor which makes it easy to swallow

Savari R, Shafiei M, Galehdari H, Kesmati M

Week 8-12: Consolidated benefits